Cargando…
Low-dose Gene Therapy Reduces the Frequency of Enzyme Replacement Therapy in a Mouse Model of Lysosomal Storage Disease
Enzyme replacement therapy (ERT) is the standard of care for several lysosomal storage diseases (LSDs). ERT, however, requires multiple and costly administrations and has limited efficacy. We recently showed that a single high dose administration of adeno-associated viral vector serotype 8 (AAV2/8)...
Autores principales: | Alliegro, Marialuisa, Ferla, Rita, Nusco, Edoardo, De Leonibus, Chiara, Settembre, Carmine, Auricchio, Alberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159621/ https://www.ncbi.nlm.nih.gov/pubmed/27658524 http://dx.doi.org/10.1038/mt.2016.181 |
Ejemplares similares
-
Non-clinical Safety and Efficacy of an AAV2/8 Vector Administered Intravenously for Treatment of Mucopolysaccharidosis Type VI
por: Ferla, Rita, et al.
Publicado: (2017) -
Enzyme replacement therapy for lysosomal storage disorders in India
por: Muranjan, Mamta
Publicado: (2014) -
Musings on genome medicine: enzyme-replacement therapy of the lysosomal storage diseases
por: Nathan, David G, et al.
Publicado: (2009) -
Risks of long-term port use in enzyme replacement therapy for lysosomal storage disorders
por: Hendriksz, Christian J., et al.
Publicado: (2018) -
A systematic review of economic evaluations of enzyme replacement therapy in Lysosomal storage diseases
por: Katsigianni, Eleni Ioanna, et al.
Publicado: (2022)